| __timestamp | Apellis Pharmaceuticals, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 22223073 |
| Thursday, January 1, 2015 | 13730311 | 6966842 |
| Friday, January 1, 2016 | 22978599 | 9000499 |
| Sunday, January 1, 2017 | 40303878 | 13741186 |
| Monday, January 1, 2018 | 105285576 | 19040000 |
| Tuesday, January 1, 2019 | 220968770 | 23559000 |
| Wednesday, January 1, 2020 | 299921000 | 31931000 |
| Friday, January 1, 2021 | 420869000 | 44981000 |
| Saturday, January 1, 2022 | 387236000 | 54234000 |
| Sunday, January 1, 2023 | 354387000 | 63806000 |
Cracking the code
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Apellis Pharmaceuticals and Viking Therapeutics have shown contrasting strategies in their R&D investments. Apellis Pharmaceuticals has consistently increased its R&D budget, peaking in 2021 with a 4000% increase from 2014. This surge underscores their aggressive pursuit of groundbreaking therapies. In contrast, Viking Therapeutics has maintained a more conservative approach, with a steady increase of approximately 187% over the same period. This strategic difference highlights the diverse paths companies take in the biotech sector. As of 2023, Apellis's R&D spending is nearly six times that of Viking, reflecting their distinct priorities and market strategies. These trends offer valuable insights into the future directions of these innovative companies.
Novartis AG or Viking Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Bristol-Myers Squibb Company vs Apellis Pharmaceuticals, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Apellis Pharmaceuticals, Inc.
Comparing Innovation Spending: United Therapeutics Corporation and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Neurocrine Biosciences, Inc. vs Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and Viking Therapeutics, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and Viking Therapeutics, Inc. Allocate Funds
Apellis Pharmaceuticals, Inc. vs Perrigo Company plc: Strategic Focus on R&D Spending
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Research and Development: Comparing Key Metrics for Apellis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.